Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Artivion, Inc.

Market Cap 1.03B 897M 831M 778M 1.46B 97.06B 1.47B 9.85B 3.82B 47.77B 3.86B 3.78B 166B P/E 2026 *
171x
P/E 2027 * 49.6x
Enterprise Value 1.03B 897M 831M 778M 1.46B 97.06B 1.47B 9.85B 3.82B 47.77B 3.86B 3.78B 166B EV / Sales 2026 *
2.11x
EV / Sales 2027 * 1.9x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.08%
1 week+3.39%
Current month-5.18%
1 month-11.17%
3 months-42.36%
6 months-54.19%
Current year-53.14%
1 week 17.6
Extreme 17.6
18.5
1 month 17.4
Extreme 17.4
19.9
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer 56 01/06/2023
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
-1.08%+3.39% - - 1.03B
-0.10%+0.26%-33.23%-16.75% 154B
+1.54%-1.07%-7.45%-11.00% 102B
-4.45%+3.12%+59.84%+56.09% 56.51B
-1.90%-3.49%-8.40%+48.53% 52.89B
+1.67%-1.55%-14.60%-44.33% 39.67B
-1.32%-1.83% - - 30.39B
+1.74%-3.85%-10.54%-44.30% 27.96B
+1.35%-0.26%+50.47%-9.42% 23.17B
-1.53%+1.14%-15.03%-5.42% 20.35B
Average -0.41%-1.30%+2.63%-3.32% 56.31B
Weighted average by Cap. -0.27%-1.24%-6.19%-2.71%

Financials

2026 *2027 *
Net sales 486M 424M 393M 368M 690M 45.9B 694M 4.66B 1.81B 22.59B 1.83B 1.79B 78.44B 540M 471M 436M 408M 766M 50.95B 770M 5.17B 2B 25.08B 2.03B 1.98B 87.08B
Net income 5.11M 4.45M 4.12M 3.86M 7.24M 482M 7.28M 48.91M 18.96M 237M 19.17M 18.75M 823M 22.61M 19.72M 18.26M 17.09M 32.06M 2.13B 32.25M 217M 83.95M 1.05B 84.88M 83.06M 3.65B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
19/06/26 18.30 -1.08%
18/06/26 18.50 +0.54%
17/06/26 18.40 +1.66%
16/06/26 18.10 +2.84%
15/06/26 17.60 -0.56%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
21.19USD
Average target price
42.00USD
Spread / Average Target
+98.21%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!